Posttransplant cyclophosphamide vs tacrolimus-based GVHD prophylaxis: lower incidence of relapse and chronic GVHD

Maurer, K; Ho, VT; Inyang, E; Cutler, C; Koreth, J; Shapiro, RM; Gooptu, M; Romee, R; Nikiforow, S; Antin, JH; Wu, CJ; Ritz, J; Soiffer, RJ; Kim, HT

Kim, HT (通讯作者),Harvard Sch Publ Hlth, Dana Farber Canc Inst, Dept Data Sci, 450 Brookline Ave, Boston, MA 02215 USA.

BLOOD ADVANCES, 2023; 7 (15): 3903

Abstract

The ability of posttransplant cyclophosphamide (PTCY) to facilitate haploidentical transplantation has spurred interest in whether PTCY can improve cl......

Full Text Link